Erratum to "Quality assurance of genotyping array for detection and typing of human papillomavirus" [J. Virol. Methods 140 (2007) 1-9] (DOI:10.1016/j.jviromet.2006.10.004);Quality assurance of genotyping array for detection and typing of human papillomavirus

Journal of Virological Methods

Volumn 140, Issue 1-2, 2007, Pages 1-9

  Lin, Ching Yu ^a,b   Chen, Hui Chi ^b,c   Lin, Ruey Wen ^a   You, San Lin ^b,c   You, Chiou Mien ^a   Chuang, Li Chung ^c,d   Pan, Mei Hung ^b,c   Lee, Mei Hsuan ^b   Chou, Yi Chun ^b   Chen, Chien Jen ^b,c  

^a King Car Food Industrial Co Ltd   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Human papillomavirus; Reliability; Reproducibility; Sensitivity; Specificity

Indexed keywords

DNA; WATER;

ARTICLE; BLOOD CELL; BLOTTING; CANCER CELL; CASKI CELL; CONTROLLED STUDY; CROSS REACTION; GENE AMPLIFICATION; GENOTYPE; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 33846604969     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.08.011     Document Type: Erratum

References (34)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
2. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 (2003) 63-73
3. Coutlee F., Gravitt P., Richardson H., Hankins C., Franco E., Lapointe N., and Voyer H. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV Study Group. J. Clin. Microbiol. 37 (1999) 1852-1857
4. Daniel R.W., Ahdieh L., Hayden D., Cu-Uvin S., and Shah K.V. Intralaboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J. Clin. Virol. 19 (2000) 187-193
5. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76 (1995) 1057-1062
6. Giuliano A.R., Papenfuss M., Abrahamsen M., Denman C., de Zapien J.G., Henze J.L., Ortega L., Brown de Galaz E.M., Stephan J., Feng J., Baldwin S., Garcia F., and Hatch K. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1129-1136
7. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., and Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38 (2000) 357-361
8. Gravitt P.E., Peyton C.L., Apple R.J., and Wheeler C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36 (1998) 3020-3027
9. Harnish D.G., Belland L.M., Scheid E.E., and Rohan T.E. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction. Mol. Cell Probes 13 (1999) 9-21
10. Holmes J., Hemmett L., and Garfield S. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies. Eur. J. Health Econ. 6 (2005) 30-37
11. Huang H.J., Huang S.L., Lin C.Y., Lin R.W., Chao F.Y., Chen M.Y., Chang T.C., Hsueh S., Hsu K.H., and Lai C.H. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int. J. Gynecol. Cancer 14 (2004) 639-649
12. Huang L.W., Chao S.L., Chen P.H., and Chou H.P. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J. Clin. Virol. 29 (2004) 271-276
13. Huang S.L., Chao A., Hsueh S., Chao F.Y., Huang C.C., Yang J.E., Lin C.Y., Yan C.C., Chou H.H., Huang K.G., Huang H.J., Wu T.I., Tseng M.J., Qiu J.T., Lin C.T., Chang T.C., and Lai C.H. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J. Clin. Microbiol. 43 (2006) 1733-1739
14. Kay P., Meehan K., and Williamson A.L. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J. Virol. Methods 105 (2002) 159-170
15. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., Suntum M., Bock J.E., Poll P.A., and Meijer C.J. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325 (2002) 572-576
16. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., and Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37 (1999) 2508-2517
17. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., ter Harmsel B., and Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153 (1998) 1731-1739
18. Kornegay J.R., Roger M., Davies P.O., Shepard A.P., Guerrero N.A., Lloveras B., Evans D., and Coutlee F. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J. Clin. Microbiol. 41 (2003) 1080-1086
19. Kulski J.K., Howard M.J., and Pixley E.C. DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women. Immunol. Cell Biol. 65 (1987) 77-84
20. Lai H.C., Sun C.A., Yu M.H., Chen H.J., Liu H.S., and Chu T.Y. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int. J. Cancer 84 (1999) 553-557
21. Lefevre J., Hankins C., Pourreaux K., Voyer H., and Coutlee F. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J. Med. Virol. 72 (2004) 132-137
22. Liaw K.L., Hsing A.W., Schiffman M.H., You S.L., Zhang T., Burk R., and Chen C.J. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int. J. Cancer 73 (1997) 775-776
23. Lowy D.R., and Frazer I.H. Chapter 16: prophylactic human papillomavirus vaccines. J. Natl. Cancer Inst. Monogr. 31 (2003) 111-116
24. Melchers W.J., Bakkers J.M., Wang J., de Wilde P.C., Boonstra H., Quint W.G., and Hanselaar A.G. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am. J. Pathol. 155 (1999) 1473-1478
25. Melchers W.J., Herbrink P., Walboomers J.M., Meijer C.J., vd Drift H., Lindeman J., and Quint W.G. Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test. J. Clin. Microbiol. 27 (1989) 106-110
26. Molano M., Van den Brule A., Plummer M., Weiderpass E., Posso H., Arslan A., Meijer C.J., Munoz N., and Franceschi S. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am. J. Epidemiol. 158 (2003) 486-494
27. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
28. Schlecht N.F. Persistence of the same HPV type over 2 years increased 800-fold the risk of developing high-grade cervical lesions. Evidence based Obstet. Gynecology 5 (2003) 90-91
29. Snijders P.J., van den Brule A.J., and Meijer C.J. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201 (2003) 1-6
30. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., and Franco E.L. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1274-1280
31. van den Brule A.J., Snijders P.J., Gordijn R.L., Bleker O.P., Meijer C.J., and Walboomers J.M. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int. J. Cancer 45 (1990) 644-649
32. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., Kravang I., Torrez-Martinez N., Peyton C.L., and Wheeler C.M. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40 (2002) 979-983
33. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
34. Wallin K.L., Wiklund F., Angstrom T., Bergman F., Stendahl U., Wadell G., Hallmans G., and Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341 (1999) 1633-1638